A bowl of yogurt on a table.

Can a Probiotic Change Your Metabolism?

A 12-week trial found 0.75 kg more weight loss on a probiotic strain than placebo — about 1% of body weight; no significant effect on blood pressure or lipids.

In 110 adults with metabolic syndrome in China, 12 weeks of Lactiplantibacillus plantarum J26 lowered body weight by 0.75 kg more than placebo — about 1% of body weight, with no significant effect on blood pressure, blood sugar or blood lipids.

A 12-week randomized, double-blind trial in 110 adults with metabolic syndrome in Guangdong, China, found daily Lactiplantibacillus plantarum J26 produced 0.75 kg (about 1.7 lb) more weight loss than placebo — about 1% of body weight, below the 5% treated as clinically meaningful — but perhaps a nice little boost to a more comprehensive WL program. Blood pressure, blood sugar and blood lipids showed no significant difference.

What this means

In adults with metabolic syndrome, one strain taken for 12 weeks produced about 0.75 kg (about 1.7 lb) more weight loss than placebo — roughly 1% of body weight, far short of the 5% that signals clinical benefit, with no significant difference in blood pressure, blood sugar or blood lipids. The capsules came from the strain’s commercial supplier, and the paper may still be edited. This study of one strain says nothing about probiotics as a category overall.

What the trial did

110 adults aged 40 to 65 at one hospital in Guangdong met at least three of five ATP III criteria for metabolic syndrome, using Asian waist cut-offs. Average BMI was 26.1 on placebo and 27.0 on J26: overweight, mostly below the obesity threshold. They were randomly assigned, double-blind, to one capsule daily for 12 weeks of L. plantarum J26 at 5 x 10^9 CFU or a matching potato-starch placebo; 107 were analyzed. The strain and placebo capsules were donated by BioGrowing Co., Ltd., and the paper reports no other funding and no competing interests.

What the numbers showed

Weight fell 0.97 kg (about 2.1 lb) on J26 and 0.22 kg (about 0.5 lb) on placebo. The difference in change was -0.75 kg (about -1.7 lb; 95% CI -1.44 to -0.06; P = 0.021) — about 1% of baseline body weight, below the 5% treated as clinically meaningful. Waist circumference differed by -1.92 cm, body fat by -0.87 percentage points. Blood pressure, fasting glucose and all four lipids showed no significant difference; the authors report no significant overall effect on blood pressure, glycemia or lipids. (The fasting-glucose difference ran the other way — up 0.31 mmol/L on J26 — but was not significant.)

What it does not show

The result belongs to L. plantarum J26 at 5 x 10^9 CFU daily, not to probiotics as a category. Eighteen secondary outcomes were tested with no multiplicity control reported for them; the paper’s stated multiplicity correction applies only to its microbiota analyses. Muscle mass differed by 0.65 kg (about 1.4 lb) in J26’s favor alongside the fat loss — unusual for a weight-loss intervention and undiscussed.

The 28 responders came from exploratory post hoc clustering the authors call hypothesis-generating, and microbiome mediation is exploratory, not an established pathway. The paper is the accepted article in press, so numbers may change; its registration record (ChiCTR2400088192) was not examined.

Where this sits

Three meta-analyses of L. plantarum’s effect on body weight since 2024 — pooling 9, 17 and 18 trials — put average weight loss near 1.2 kg and waist circumference near 1.4 cm, far below the 5% body-weight change usually treated as clinically meaningful; the newest review’s own conclusion calls the benefit “modest yet clinically meaningful” in obesity management.

Terms explained

  • CFU — colony-forming units, the live bacteria count in a dose.
  • Metabolic syndrome — a cluster of risk markers; here, at least three of five criteria.
  • Confidence interval — the range of values consistent with the data; one excluding zero supports a real difference.

Sources

  1. Zheng J, Yang M, Zhuang J, et al. Lactiplantibacillus plantarum J26 supplementation improves adiposity-related outcomes in adults with metabolic syndrome via remodeling the gut microbiota. npj Science of Food, published online 2026-08-28. doi:10.1038/s41538-026-01114-w (accepted, unedited version).
  2. Khattak MH, Abbas SA, Zaryab U, et al. Influence of Lactobacillus plantarum on anthropometric and inflammatory parameters in obesity: a GRADE-assessed systematic review and meta-analysis of randomized controlled trials. Int J Obes (Lond). 2026. doi:10.1038/s41366-026-02221-0. PMID: 42773221.
  3. Cheng Z, Du L, Zheng W, et al. Efficacy of Lactobacillus plantarum on Body Composition, Lipid Profile, Liver Enzymes, and Inflammatory Markers in Overweight or Obese Adults: A GRADE Systematic Review and Meta-analysis of Randomized Trials. Probiotics Antimicrob Proteins. 2026. doi:10.1007/s12602-026-11137-0. PMID: 42518167.
  4. Li CP, Chen CC, Hsiao Y, et al. The Role of Lactobacillus plantarum in Reducing Obesity and Inflammation: A Meta-Analysis. Int J Mol Sci. 2024;25:7608. doi:10.3390/ijms25147608. PMID: 39062848.
  5. Press signal, framing only: NutraIngredients, 2026-10-20. https://www.nutraingredients.com/Article/2026/10/20/probiotic-intake-lowers-body-weight-bmi-but-effects-on-lipid-profile-limited/

Related Articles